In the largest genomic study ever published on any psychiatric disorder, scientists have identified more than 100 locations in the human genome linked to the development of schizophrenia. The hope, of course, is that these discoveries could lead to new treatments for the disorder, which is a debilitating disease affecting 1 in 100 people worldwide.
In a live announcement this morning from the Broad Institute, which was part of the international team leading the study, Founding Director Eric Lander called the news a “revolution in the study of psychiatric disease.”
In that same announcement, National Institutes of Health Director Francis Collins said that scientists are poised for real advancement in psychiatric research. “I’m impatient,” he said. “Everybody listening to this announcement is impatient as well. But that impatience is being met with resolve. We’re not just going to wring our hands. We’re going to do something.”
Also making news this morning: philanthropist Ted Stanley’s $650 million commitment to the Broad Institute’s Stanley Center for Psychiatric Research. Stanley’s commitment is the largest ever in the study of mental illness.